| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.54B | 19.01B | 17.77B | 7.61B | 3.82B |
| Gross Profit | 5.59B | 5.96B | 3.03B | -198.60M | -1.51B |
| EBITDA | 5.71B | 5.62B | 4.21B | 853.40M | -791.30M |
| Net Income | 2.78B | 2.67B | 2.16B | -962.00M | -4.27B |
Balance Sheet | |||||
| Total Assets | 43.09B | 44.26B | 50.19B | 49.72B | 37.58B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 12.66B | 16.73B | 14.17B | 8.05B |
| Total Debt | 12.91B | 13.45B | 15.34B | 15.92B | 14.56B |
| Total Liabilities | 27.02B | 27.52B | 29.94B | 26.92B | 21.30B |
| Stockholders Equity | 15.66B | 16.34B | 19.86B | 22.41B | 15.91B |
Cash Flow | |||||
| Free Cash Flow | 2.83B | 3.73B | 7.47B | -289.20M | -6.21B |
| Operating Cash Flow | 4.71B | 5.05B | 9.15B | 2.83B | -3.44B |
| Investing Cash Flow | -3.30B | -1.44B | -490.10M | -2.32B | -1.40B |
| Financing Cash Flow | -4.33B | -8.78B | -5.88B | 5.16B | 9.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $16.29B | 12.16 | 140.98% | 3.50% | 6.81% | 58.22% | |
73 Outperform | $33.54B | 13.31 | 28.00% | 1.37% | 14.75% | 71.73% | |
71 Outperform | $17.35B | 9.67 | 14.98% | 6.16% | 3.86% | 15.58% | |
71 Outperform | $37.82B | 10.76 | 23.99% | ― | 4.24% | 20.29% | |
70 Outperform | $46.44B | 9.29 | 27.70% | 0.96% | 4.33% | -1.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | $9.31B | 80.37 | ― | ― | 1.27% | 118.64% |